Palivizumab er et humaniseret IgG1K monoklonalt antistof rettet mod en epitop på det A antigene sted på fusionsproteinet af respiratorisk syncytialvirus (RSV).
Palivizumab is a humanised IgG1κ monoclonal antibody directed to an epitope in the A antigenic site of the fusion protein of respiratory syncytial virus (RSV).